Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
AORT Quote, Financials, Valuation and Earnings
Last price:
$46.29
Seasonality move
:
0.17%
Day range:
$45.75 - $47.06
52-week range:
$21.97 - $48.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.88x
P/B ratio:
5.00x
Volume:
221.4K
Avg. volume:
379K
1-year change:
57.84%
Market cap:
$2.2B
Revenue:
$388.5M
EPS (TTM):
-$0.24
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AORT
Artivion, Inc.
|
$112.8M | $0.13 | 19.64% | -75% | $51.71 |
|
EW
Edwards Lifesciences Corp.
|
$1.6B | $0.68 | 11.31% | -5.18% | $95.80 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.2M | -- | -54.48% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$765K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
PLSE
Pulse Biosciences, Inc.
|
$500K | -- | -- | -- | $22.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AORT
Artivion, Inc.
|
$46.31 | $51.71 | $2.2B | -- | $0.00 | 0% | 4.88x |
|
EW
Edwards Lifesciences Corp.
|
$86.85 | $95.80 | $50.4B | 36.97x | $0.00 | 0% | 8.68x |
|
IVF
INVO Fertility, Inc.
|
$0.84 | -- | $12.7M | -- | $0.00 | 0% | 0.02x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.73 | $2.23 | $36.8M | -- | $0.00 | 0% | 2.42x |
|
NTRB
Nutriband, Inc.
|
$4.80 | $15.00 | $58.3M | -- | $0.00 | 0% | 23.95x |
|
PLSE
Pulse Biosciences, Inc.
|
$14.40 | $22.00 | $968.7M | -- | $0.00 | 0% | 11,044.59x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AORT
Artivion, Inc.
|
37.39% | 2.234 | 13.06% | 1.88x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.140 | 1.55% | 2.86x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 2.039 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.796 | 0.32% | 7.07x |
|
PLSE
Pulse Biosciences, Inc.
|
7.84% | 1.721 | 0.66% | 9.82x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AORT
Artivion, Inc.
|
$70.9M | $11.6M | -1.36% | -2.63% | 10.26% | $15.9M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $433.1M | 12.34% | 13.19% | 27.89% | $516.2M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
PLSE
Pulse Biosciences, Inc.
|
-$449K | -$20.4M | -67.74% | -73.32% | -23682.56% | -$13.1M |
Artivion, Inc. vs. Competitors
-
Which has Higher Returns AORT or EW?
Edwards Lifesciences Corp. has a net margin of 5.73% compared to Artivion, Inc.'s net margin of 18.82%. Artivion, Inc.'s return on equity of -2.63% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital AORTArtivion, Inc.62.55% $0.13 $700.7M EWEdwards Lifesciences Corp.78.29% $0.50 $10.9B -
What do Analysts Say About AORT or EW?
Artivion, Inc. has a consensus price target of $51.71, signalling upside risk potential of 11.67%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $95.80 which suggests that it could grow by 10.31%. Given that Artivion, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Artivion, Inc. is more attractive than Edwards Lifesciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings AORTArtivion, Inc.4 1 0 EWEdwards Lifesciences Corp.15 13 0 -
Is AORT or EW More Risky?
Artivion, Inc. has a beta of 1.601, which suggesting that the stock is 60.125% more volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.229%.
-
Which is a Better Dividend Stock AORT or EW?
Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AORT or EW?
Artivion, Inc. quarterly revenues are $113.4M, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Artivion, Inc.'s net income of $6.5M is lower than Edwards Lifesciences Corp.'s net income of $292.3M. Notably, Artivion, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 36.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 4.88x versus 8.68x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORTArtivion, Inc.4.88x -- $113.4M $6.5M EWEdwards Lifesciences Corp.8.68x 36.97x $1.6B $292.3M
-
Which has Higher Returns AORT or IVF?
INVO Fertility, Inc. has a net margin of 5.73% compared to Artivion, Inc.'s net margin of -150.51%. Artivion, Inc.'s return on equity of -2.63% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital AORTArtivion, Inc.62.55% $0.13 $700.7M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About AORT or IVF?
Artivion, Inc. has a consensus price target of $51.71, signalling upside risk potential of 11.67%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 17091.98%. Given that INVO Fertility, Inc. has higher upside potential than Artivion, Inc., analysts believe INVO Fertility, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AORTArtivion, Inc.4 1 0 IVFINVO Fertility, Inc.0 0 0 -
Is AORT or IVF More Risky?
Artivion, Inc. has a beta of 1.601, which suggesting that the stock is 60.125% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock AORT or IVF?
Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AORT or IVF?
Artivion, Inc. quarterly revenues are $113.4M, which are larger than INVO Fertility, Inc. quarterly revenues of $1.8M. Artivion, Inc.'s net income of $6.5M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Artivion, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 4.88x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORTArtivion, Inc.4.88x -- $113.4M $6.5M IVFINVO Fertility, Inc.0.02x -- $1.8M -$2.6M
-
Which has Higher Returns AORT or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of 5.73% compared to Artivion, Inc.'s net margin of -59.08%. Artivion, Inc.'s return on equity of -2.63% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital AORTArtivion, Inc.62.55% $0.13 $700.7M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About AORT or NMTC?
Artivion, Inc. has a consensus price target of $51.71, signalling upside risk potential of 11.67%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 204.92%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Artivion, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AORTArtivion, Inc.4 1 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is AORT or NMTC More Risky?
Artivion, Inc. has a beta of 1.601, which suggesting that the stock is 60.125% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock AORT or NMTC?
Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AORT or NMTC?
Artivion, Inc. quarterly revenues are $113.4M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Artivion, Inc.'s net income of $6.5M is higher than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Artivion, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 4.88x versus 2.42x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORTArtivion, Inc.4.88x -- $113.4M $6.5M NMTCNeuroOne Medical Technologies Corp.2.42x -- $2.7M -$1.6M
-
Which has Higher Returns AORT or NTRB?
Nutriband, Inc. has a net margin of 5.73% compared to Artivion, Inc.'s net margin of -1118.87%. Artivion, Inc.'s return on equity of -2.63% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital AORTArtivion, Inc.62.55% $0.13 $700.7M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About AORT or NTRB?
Artivion, Inc. has a consensus price target of $51.71, signalling upside risk potential of 11.67%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 212.5%. Given that Nutriband, Inc. has higher upside potential than Artivion, Inc., analysts believe Nutriband, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AORTArtivion, Inc.4 1 0 NTRBNutriband, Inc.1 0 0 -
Is AORT or NTRB More Risky?
Artivion, Inc. has a beta of 1.601, which suggesting that the stock is 60.125% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock AORT or NTRB?
Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AORT or NTRB?
Artivion, Inc. quarterly revenues are $113.4M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Artivion, Inc.'s net income of $6.5M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, Artivion, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 4.88x versus 23.95x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORTArtivion, Inc.4.88x -- $113.4M $6.5M NTRBNutriband, Inc.23.95x -- $346.1K -$3.9M
-
Which has Higher Returns AORT or PLSE?
Pulse Biosciences, Inc. has a net margin of 5.73% compared to Artivion, Inc.'s net margin of -22540.7%. Artivion, Inc.'s return on equity of -2.63% beat Pulse Biosciences, Inc.'s return on equity of -73.32%.
Company Gross Margin Earnings Per Share Invested Capital AORTArtivion, Inc.62.55% $0.13 $700.7M PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M -
What do Analysts Say About AORT or PLSE?
Artivion, Inc. has a consensus price target of $51.71, signalling upside risk potential of 11.67%. On the other hand Pulse Biosciences, Inc. has an analysts' consensus of $22.00 which suggests that it could grow by 52.78%. Given that Pulse Biosciences, Inc. has higher upside potential than Artivion, Inc., analysts believe Pulse Biosciences, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AORTArtivion, Inc.4 1 0 PLSEPulse Biosciences, Inc.1 0 0 -
Is AORT or PLSE More Risky?
Artivion, Inc. has a beta of 1.601, which suggesting that the stock is 60.125% more volatile than S&P 500. In comparison Pulse Biosciences, Inc. has a beta of 1.806, suggesting its more volatile than the S&P 500 by 80.579%.
-
Which is a Better Dividend Stock AORT or PLSE?
Artivion, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pulse Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Artivion, Inc. pays -- of its earnings as a dividend. Pulse Biosciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AORT or PLSE?
Artivion, Inc. quarterly revenues are $113.4M, which are larger than Pulse Biosciences, Inc. quarterly revenues of $86K. Artivion, Inc.'s net income of $6.5M is higher than Pulse Biosciences, Inc.'s net income of -$19.4M. Notably, Artivion, Inc.'s price-to-earnings ratio is -- while Pulse Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Artivion, Inc. is 4.88x versus 11,044.59x for Pulse Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORTArtivion, Inc.4.88x -- $113.4M $6.5M PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
